Pleotropic effects of cilnidipine in patients with hypertension

Pleotropic effects of cilnidipine in patients with hypertension - Pleotropic effects of cilnidipine

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015215

Enrollment

Registered

2014-11-01

Start date

2014-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with hypertension

Interventions

ARB/amlodipine is switched to ARB/ cilnidipine ARB/ cilnidipine is switched to ARB/amlodipine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hypertensive patients with ARB/ amlodipine

Exclusion criteria

Exclusion criteria: Patients with no consensus

Design outcomes

Primary

Measure	Time frame
Blood pressure lowering effects	—

Secondary

Measure	Time frame
Pleiotropic effects	—

Countries

Japan

Contacts

Public ContactShusuke Yagi

The University of Tokushima Graduate School of Health Biosciences Department of Cardiovascular Medicine

syagi@tokushima-u.ac.jp088-633-7851

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026